This is filed to report tachycardia and atrial flutter treated by catheter ablation which is considered medical intervention it was reported through a research article identifying a case study in which a (b)(6) year-old man who underwent a mustard operation in 1972 followed by a second cardiac intervention in 1996 for pulmonary venous baffle enlargement had mitraclip procedure to treat tricuspid regurgitation (tr) with grade 3.The patient was considered high-risk for surgical intervention.Thus, off-label percutaneous repair using the mitraclip was recommended for potential bridge to transplantation.One xtr clip was implanted, reducing tr to 2.The patient was discharged day 2 after the procedure and came back at 7 days with dyspnea and tachycardia associated with atrial flutter.The patient underwent a computerized tomography (ct) to exclude a thrombus in the systemic atrium, which also confirmed the position of the clip.The patient was treated by catheter ablation and discharged on the next day in sinus rhythm on rivaroxaban and his home heart failure medications.Clinical and echographic assessment at 1- and 6-month showed major clinical improvement.Details are listed in the attached article, titled edge to edge repair using a mitraclip for severe tricuspid valve regurgitation after a mustard operation.No additional information was provided.
|
The device was not returned for analysis and a review of the lot history record could not be performed as the part and lot information regarding the complaint device was not provided.Based on the information reviewed, a conclusive cause for the reported atrial flutter, dyspnea and tachycardia could not be determined in this complaint.The reported patient effects of atrial flutter, dyspnea and tachycardia as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.The unexpected medical intervention were a result of case-specific circumstance as documented within this article.Although a conclusive cause for the reported patient effect and the relationship to the device, if any, cannot be determined, there is no indication of a product issue with respect to manufacture, design or labeling.
|